Algen is a startup based in the United States, 1 tracked investor.
Algen is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Algen develops advanced CRISPR gene-modulation technology combined with AI-driven deep learning models to accelerate therapeutic drug discovery by mapping disease trajectories and RNA signaling networks.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.